Related references
Note: Only part of the references are listed.Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
Shuang-Jia Wang et al.
CANCER LETTERS (2010)
Noscapine, a Benzylisoquinoline Alkaloid, Sensitizes Leukemic Cells to Chemotherapeutic Agents and Cytokines by Modulating the NF-κB Signaling Pathway
Bokyung Sung et al.
CANCER RESEARCH (2010)
Clinicopathological features and treatment strategy for triple-negative breast cancer
Yutaka Yamamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers
Ram R. Patlolla et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Farrah Kassam et al.
CLINICAL BREAST CANCER (2009)
Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non-Small Cell Lung Cancer
Nkechi Ichite et al.
CLINICAL CANCER RESEARCH (2009)
EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells
Prasanthi Karna et al.
MOLECULAR CANCER (2009)
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
Edith A. Perez
MOLECULAR CANCER THERAPEUTICS (2009)
The Anti-Cancer Activity of Noscapine: A Review
Massoud Mahmoudian et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2009)
Antitumor activity of noscapine in human non-small cell lung cancer xenograft model
Tanise Jackson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Triple-negative breast cancer
Gert Stockmans et al.
CURRENT OPINION IN ONCOLOGY (2008)
What is triple-negative breast cancer?
William J. Irvin et al.
EUROPEAN JOURNAL OF CANCER (2008)
Antiangiogenic effects of noscapine enhance radioresponse for gl261 tumors
Elizabeth W. Newcomb et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer
Penelope D. Ottewell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Effect of noscapine and vincristine combination on demyelination and cell proliferation in vitro
Laree Hiser et al.
LEUKEMIA & LYMPHOMA (2008)
Advances in the treatment of breast cancer
S. Moulder et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
Bhumsuk Keam et al.
BMC CANCER (2007)
Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent
Ritu Aneja et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Apoptotic pathway induced by noscapine in human myelogenous leukemic cells
Nastaran Heidari et al.
ANTI-CANCER DRUGS (2007)
p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells
Ritu Aneja et al.
CANCER RESEARCH (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice
Ritu Aneja et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice
Andrew Ewens et al.
CANCER RESEARCH (2006)
Rational design of the microtubule-targeting anti-breast cancer drug EM015
R Aneja et al.
CANCER RESEARCH (2006)
Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011
R Aneja et al.
BLOOD (2006)
Identification of novel and improved antimitotic agents derived from noscapine
JT Anderson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Discovery of S-phase arresting agents derived from noscapine
JT Anderson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth
JW Landen et al.
CLINICAL CANCER RESEARCH (2004)
Evaluation of combination chemotherapy: Integration of nonlinear regression, curve shift, isobologram, and combination index analyses
L Zhao et al.
CLINICAL CANCER RESEARCH (2004)
Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer
AU Buzdar
ONCOLOGIST (2003)
Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine
J Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
NF-κB activation plays an important role in the IL-4-induced protection from apoptosis
J Zamorano et al.
INTERNATIONAL IMMUNOLOGY (2001)
Role of formulation vehicles in taxane pharmacology
L van Zuylen et al.
INVESTIGATIONAL NEW DRUGS (2001)
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
JA Menéndez et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
